VIDOVÁ, Veronika, Eliška STUCHLÍKOVÁ, Markéta VRBOVÁ, Martina ALMÁŠI, Jana KLÁNOVÁ, Vojtěch THON and Zdeněk SPÁČIL. Multiplex Assay for Quantification of Acute Phase Proteins and Immunoglobulin A in Dried Blood Spots. Journal of Proteome Research. Washington, USA: AMER CHEMICAL SOC, 2019, vol. 18, No 1, p. 380-391. ISSN 1535-3893. Available from: https://dx.doi.org/10.1021/acs.jproteome.8b00657.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Multiplex Assay for Quantification of Acute Phase Proteins and Immunoglobulin A in Dried Blood Spots
Authors VIDOVÁ, Veronika (203 Czech Republic, belonging to the institution), Eliška STUCHLÍKOVÁ (203 Czech Republic, belonging to the institution), Markéta VRBOVÁ (203 Czech Republic, belonging to the institution), Martina ALMÁŠI (203 Czech Republic), Jana KLÁNOVÁ (203 Czech Republic, belonging to the institution), Vojtěch THON (203 Czech Republic, belonging to the institution) and Zdeněk SPÁČIL (203 Czech Republic, guarantor, belonging to the institution).
Edition Journal of Proteome Research, Washington, USA, AMER CHEMICAL SOC, 2019, 1535-3893.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10609 Biochemical research methods
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW Full Text
Impact factor Impact factor: 4.074
RIV identification code RIV/00216224:14310/19:00107209
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1021/acs.jproteome.8b00657
UT WoS 000455285900034
Keywords in English inflammation markers; acute phase proteins; immune response; dried blood spots; targeted quantitative proteomics; selected reaction monitoring
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 12/3/2020 11:39.
Abstract
Inflammation is the first line defense mechanism against infection, tissue damage, or cancer development. However, inappropriate inflammatory response may also trigger diseases. The quantification of inflammatory proteins is essential to distinguish between harmful and beneficial immune response. Currently used immunoanalytical assays may suffer specificity issues due to antigen-antibody interaction and possible cross-reactivity of antibody with other protein species. In addition, immunoanalytical assays typically require invasive blood sampling and additional logistics; they are relatively costly and highly challenging to multiplex. We present a multiplex assay based on selected reaction monitoring (SRM) for quantification of seven acute-phase proteins (i.e., SAA1, SAA2-isoform1, SAA4, CRP, A1AT-isoform1, A1AG1, A1AG2) and the adaptive immunity effector IGHA1 in dried blood spots. This type of sample is readily available from all human subjects including newborns. The study utilizes proteotypic isotopically labeled peptides with trypsin-cleavable tag and presents optimized and reproducible workflow and several important practical remarks regarding quantitative SRM assays development. The panel of inflammatory proteins was quantified with sequence specificity capable to differentiate protein isoforms with intra- and interday precision (<16.4% coefficient of variation (CV) and <14.3% CV, respectively). Quantitative results were correlated with immuno-nephelometric assay (typically greater than 0.9 Pearson's R).
Links
EF15_003/0000469, research and development projectName: Cetocoen Plus
GJ17-24592Y, research and development projectName: Mapování interakcí mezi základními metabolickými pochody a střevní mikroflórou
Investor: Czech Science Foundation
LM2015051, research and development projectName: Centrum pro výzkum toxických látek v prostředí (Acronym: RECETOX RI)
Investor: Ministry of Education, Youth and Sports of the CR
PrintDisplayed: 23/7/2024 20:13